Invalidity of Method of Treatment Patent for Lack of Written Description in Hatch-Waxman Case
The Federal Circuit affirmed the Northern District of West Virginia’s invalidity finding as to a method-of-treatment patent, based on a lack of written description.
West Virginia United States Plaintiffs Biogen International Gmb Biogen Ma Inc Mylan Pharmaceuticals Inc Federal Circuit
Source: natlawreview.com